Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathyDiane C Zelman
California School of Professional Psychology-Alliant International University, San Francisco, California 94133-1221, USA
J Pain Symptom Manage 29:401-10. 2005
..The BPI-DPN is a promising instrument in the evaluation of painful DPN...
- Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care
Mugdha Gore
Avalon Health Solutions, Inc, Philadelphia, PA 19102, USA
J Med Econ 15:19-31. 2012
..To assess comorbidities, pain-related pharmacotherapy, and healthcare resource use among patients with fibromyalgia (FM) newly prescribed pregabalin or duloxetine (index event) in usual care settings...
- Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with fibromyalgia newly prescribed pregabalin or tricyclic antidepressants
Mugdha Gore
Avalon Health Solutions, Inc, Philadelphia, PA 19102, USA
J Med Econ 15:32-44. 2012
..To examine treatment patterns and costs among patients with fibromyalgia prescribed pregabalin or tricyclic antidepressants (TCAs)...
- Selecting an appropriate medication for treating neuropathic pain in patients with diabetes: a study using the U.K. and Germany Mediplus databases
Mugdha Gore
Avalon Health Solutions, Inc, Philadelphia, Pennsylvania 19103, USA
Pain Pract 8:253-62. 2008
....
- Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care
Mugdha Gore
Avalon Health Solutions, Inc, Philadelphia, Pennsylvania 19102, USA
Pain Pract 11:167-79. 2011
..To evaluate treatment patterns and costs among patients with painful diabetic peripheral neuropathy (pDPN) newly prescribed pregabalin or duloxetine in usual care settings...
- Initial use of pregabalin, patterns of pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia
Mugdha Gore
Avalon Health Solutions, Inc, 1518 Walnut St, Ste 1507, Philadelphia, PA 19102, USA
Am J Manag Care 16:S144-53. 2010
..To characterize the comorbidities, pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia (FM) newly prescribed pregabalin in clinical practice...
- Clinical characteristics, pharmacotherapy and healthcare resource use among patients with fibromyalgia newly prescribed gabapentin or pregabalin
Mugdha Gore
Avalon Health Solutions, Inc, Philadelphia, Pennsylvania 19103, USA
Pain Pract 9:363-74. 2009
..To characterize comorbidities, pain-related pharmacotherapy, and healthcare resource use among patients with fibromyalgia (FM) newly prescribed pregabalin or gabapentin in clinical practice...
- Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis
Mugdha Gore
Avalon Health Solutions, Inc, 1518 Walnut Steeet, Philadelphia, PA 19102, USA
J Med Econ 14:497-507. 2011
..The purpose of this study was to examine comorbidities, pain-related pharmacotherapy, and direct medical costs of patients with OA in clinical practice...
- A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings
Mugdha Gore
Avalon Health Solutions, Inc, Philadelphia, Pennsylvania 19102, USA
Clin Ther 29:1655-70. 2007
..Both gabapentin and pregabalin are approved for the management of postherpetic neuralgia (PHN), although dosing and pharmacokinetic differences between these medications may affect their use in actual practice...
- Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives
Mugdha Gore
Avalon Health Solutions, Inc, Philadelphia, Pennsylvania 19102, USA
J Pain 7:892-900. 2006
..Results also suggest suboptimal pain management and low levels of satisfaction with treatments...
- Prevalence of contraindicated medical conditions and use of precluded medications in patients with painful neuropathic disorders prescribed amitriptyline
Mugdha Gore
Avalon Health Solutions, Inc, Philadelphia, Pennsylvania 19102, USA
Pain Pract 6:265-72. 2006
..However, the clinical significance of these data is, as yet, unclear. Although, in theory, adverse outcomes may have been associated with this practice, we could not confirm this with this database analysis...
- Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings
Mugdha Gore
Avalon Health Solutions Inc, Philadelphia, PA 19102, USA
Eur J Pain 11:652-64. 2007
....
- Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis
Mugdha Gore
Avalon Health Solutions, Inc, Philadelphia, Pennsylvania 19102, USA
Clin Ther 33:1914-31. 2011
..Osteoarthritis (OA) is a debilitating condition characterized by chronic pain. Several pain medications are recommended, and patients frequently alternate among these medications...
- Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin
Mugdha Gore
Avalon Health Solutions, Inc, Philadelphia, Pennsylvania 19102, USA
Pain Pract 11:528-39. 2011
..To characterize comorbidities, pain-related pharmacotherapy, and healthcare resource use among patients with painful diabetic peripheral neuropathy (pDPN) newly prescribed pregabalin or gabapentin in clinical practice...
- Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep
Mugdha Gore
Avalon Health Solutions, Inc, Philadelphia, Pennsylvania 19102, USA
J Pain Symptom Manage 30:374-85. 2005
..01). Painful DPN is associated with decrements in many aspects of patients' lives: physical and emotional functioning, affective symptoms, and sleep problems. The negative impact is higher in patients with greater pain severity...
- The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings
Mugdha Gore
Avalon Health Solutions, Inc, Philadelphia, PA Pfizer, Inc, New York, NY Oregon Health and Science University, Portland, OR and Department of Public Health Sciences, Pennsylvania State University, College of Medicine, Hershey, PA
Spine (Phila Pa 1976) 37:E668-77. 2012
..This economic burden can be attributed to greater prescribing of pain-related medications and increased health resource utilization...
- Sleep impairment in patients with painful diabetic peripheral neuropathy
Diane C Zelman
California School of Professional Psychology, Alliant International University, One Beach Street, San Francisco, CA 94133-122, USA
Clin J Pain 22:681-5. 2006
....
- Validation of a modified version of the Brief Pain Inventory for painful diabetic peripheral neuropathy
Diane C Zelman
California School of Professional Psychology-Alliant International University, San Francisco, CA 94133, USA
J Vasc Nurs 23:97-104. 2005
..The BPI-DPN is a promising instrument in the evaluation of painful DPN...
- Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy
Diane C Zelman
California School of Professional Psychology, Alliant International University, One Beach St, San Francisco, CA 94133 1221, USA
Pain 115:29-36. 2005
..This research shows that three categories of DPN pain severity can be identified based on interference with daily function, and that these categories are associated with patient outcomes and medical utilization...
